top of page

Visiting Stanford's Innovative Medicines Accelerator

Chaitan Khosla, Director of the Innovative Medicines Accelerator, describes how Stanford goes extra lengths to turn its research into licensable assets for the biopharmaceutical industry.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page